Medidata Rave Selected by Wyeth Pharmaceuticals for Enterprise-Wide EDC Deployment

    Industry-Leading Global Pharmaceutical Company Looks to Medidata
Solutions to Improve Clinical Development Process and Further Build R&D

    NEW YORK, October 23 /CNW/ - Medidata Solutions, a global provider of
electronic clinical data capture (EDC), management and reporting solutions,
today announced that Wyeth Pharmaceuticals, a division of Wyeth (NYSE:   WYE),
has selected Medidata Rave(R) as its enterprise-wide EDC solution. This
strategic partnership with Medidata will further enhance Wyeth's clinical
operations and build upon successful EDC programs already in place.

    "The deployment of EDC technology has been an extremely important
initiative at Wyeth - in the past 11 months, we have increased the rate of EDC
usage in trials to more than 90 percent," said Ira Spector, Vice President of
Clinical Development Operations at Wyeth Research. "The implementation of
Medidata Rave is critical to our ability to further increase and maximize our
EDC usage while continuing to improve the overall productivity of our R&D

    One of the top 10 largest pharmaceutical companies in the world, Wyeth
plans to conduct several hundred global studies using Medidata Rave during a
seven-year term, with the first trial beginning in the first quarter of 2008.

    In order to select its next-generation EDC solution that would support
the increasing volume of its R&D pipeline, Wyeth conducted an evaluation of
vendors in 2006. Wyeth narrowed its selection to two leading companies and
chose Medidata Solutions for Rave's breadth of functionality as well as the
company's depth of experience in the marketplace and overall corporate
culture. Wyeth anticipates Medidata Rave will bring higher productivity and
increased efficiencies and also offer a range of ease-of-use capabilities to
the investigators that are of such critical importance to the clinical trial

    "We are extremely pleased that Wyeth has selected Medidata Rave as its
enterprise-wide EDC solution and are committed to collaborating with the
company to advance its clinical processes," said Tarek Sherif, CEO at Medidata
Solutions. "Wyeth's strategic decision to move to Medidata Rave as its EDC
standard is further proof that our industry-leading technology is the system
of choice for life sciences companies of all sizes. Over the past two years,
we have seen the industry increasingly move to global, enterprise-wide
implementations of Medidata Rave, reflecting the versatility and scalability
of our product and services."

    About Medidata Solutions Worldwide

    Medidata Solutions helps the world's leading pharmaceutical,
biotechnology, medical device and research organizations maximize the value of
their clinical research investments. Innovative process design, technology and
services streamline clinical trials by providing early visibility to reliable
clinical data - the lifeblood of every research organization. Working with
companies and institutions both large and small, Medidata Solutions helps
clinical researchers safely accelerate the process of bringing life-enhancing
treatments to market - on six continents and in more than 80 countries.
Medidata Solutions brings significant value to its broad client base with deep
clinical experience and expertise in more than 20 therapeutic areas, projects
in Phase I, II, III, IV, registries and surveillance, and studies with
thousands of investigators and tens-of-thousands of subjects. For more
information, please visit

For further information:

For further information: Lois Paul & Partners Susan Lombardo,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890